子宫内膜癌高风险女性的前瞻性临床队列研究
该研究在梅奥诊所前瞻性纳入1205名45岁及以上接受子宫内膜评估的女性,评估子宫内膜癌危险因素并采集生物样本。子宫内膜癌患病率为4.1%(n=49),年龄和BMI与子宫内膜癌正相关,激素治疗使用和吸烟与子宫内膜癌负相关。作者认为已确定的危险因素在高风险人群中区分度可能较低。
要点
- 子宫内膜癌患病率4.1%(n=49),主要见于绝经后女性(85.7%)。
- 年龄(OR 1.14)和BMI(OR 1.39)与子宫内膜癌正相关。
- 激素治疗使用(OR 0.42)和吸烟(OR 0.43)与子宫内膜癌负相关。
核心结论
- 已确定的子宫内膜癌危险因素在高风险人群中区分度可能较低,未来分析将整合危险因素评估与生物标志物检测。
研究设计与样本
- 前瞻性临床队列研究,2013年2月至2018年6月在梅奥诊所纳入1205名45岁及以上接受子宫内膜评估的女性。
主要发现
- 子宫内膜癌患病率为4.1%(n=49),其中85.7%在绝经后女性中诊断。
- 年龄(OR 1.14,95%CI 1.1-1.2)和BMI(OR 1.39,95%CI 1.1-1.7)与子宫内膜癌正相关。
- 年龄(OR 1.07,95%CI 1.0-1.1)和BMI(OR 2.00,95%CI 1.5-2.6)与非典型增生正相关。
- 年龄(OR 1.06,95%CI 1.0-1.1)和BMI(OR 1.17,95%CI 1.0-1.3)与息肉正相关。
- 激素治疗使用(OR 0.42,95%CI 0.2-0.9)和吸烟(OR 0.43,95%CI 0.2-0.9)与子宫内膜癌负相关;产次和既往口服避孕药使用与子宫内膜癌无关联。
关键数值与推荐
- 阴道棉条和Tao刷采样分别从99%和68%的女性中获得。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate endometrial cancer (EC) risk assessment and early detection strategies in high-risk populations, we designed a large, prospective cohort study of women undergoing endometrial evaluation to assess risk factors and collect novel biospecimens for future testing of emerging EC biomarkers. Here we report on the baseline findings of this study. METHODS: Women aged ≥45 years were enrolled at the Mayo Clinic from February 2013-June 2018. Risk factors included age, body mass index (BMI), smoking, oral contraceptive and hormone therapy use, and parity. We collected vaginal tampons, endometrial biopsies, and Tao brush samples. We estimated mutually-adjusted odds ratios (OR) and 95% confidence intervals (CI) using multinomial logistic regression; outcomes included EC, atypical hyperplasia, hyperplasia without atypia, disordered proliferative endometrium, and polyps, versus normal endometrium. RESULTS: Subjects included 1205 women with a mean age of 55 years; 55% were postmenopausal, and 90% had abnormal uterine bleeding. The prevalence of EC was 4.1% (n = 49), predominantly diagnosed in postmenopausal women (85.7%). Tampons and Tao brushings were obtained from 99% and 68% of women, respectively. Age (OR 1.14, 95% CI 1.1-1.2) and BMI (OR 1.39, 95% CI 1.1-1.7) were positively associated with EC; atypical hyperplasia (OR 1.07, 95% CI 1.0-1.1; OR 2.00, 95% CI 1.5-2.6, respectively), and polyps (OR 1.06, 95% CI 1.0-1.1; OR 1.17, 95% CI 1.0-1.3, respectively); hormone therapy use and smoking were inversely associated with EC (OR 0.42, 95%, 0.2-0.9; OR 0.43, 95% CI, 0.2-0.9, respectively). Parity and past oral contraception use were not associated with EC. CONCLUSIONS: Well-established EC risk factors may have less discriminatory accuracy in high-risk populations. Future analyses will integrate risk factor assessment with biomarker testing for EC detection.
引用
- Clarke MA, Long BJ, Sherman ME, et al. A prospective clinical cohort study of women at increased risk for endometrial cancer. Gynecol Oncol. 2019. PMID: 31718832. doi:10.1016/j.ygyno.2019.09.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。